1-6 of 6
Lisa l Wood, RN
Close
Sort by
Journal Articles

Single Center Retrospective Comparison of Gvhd Preventive Regimens after Cy/Flu Minimal Intensity Allotransplantation

Praveen Ranganath, MBBS, Michael J. Robertson, MD, Rafat Abonour, MD, Jennifer E. Schwartz, MD FRCP(C), Sherif Farag, MBBS, PhD, Lisa l Wood, RN, Patrick Kiel, PharmD, Robert Nelson
Journal: Blood
Blood (2014) 124 (21): 5874.
https://doi.org/10.1182/blood.V124.21.5874.5874
Published: 2014
Journal Articles

A Phase I/II Trial Combining High-Dose Lenalidomide with Melphalan and Autologous Transplant for Multiple Myeloma: A Report of the Phase I Dose-Finding Study.

Attaya Suvannasankha, MD, Sherif Farag, MD, PhD, FRACP, FRCPA, Rebecca Silbermann, M.D., Robin Obryant, RN, Lisa l Wood, RN, Abigail Huljak, Angie Secrest, Colin D. Crean, Rafat Abonour, MD
Journal: Blood
Blood (2012) 120 (21): 3146.
https://doi.org/10.1182/blood.V120.21.3146.3146
Published: 2012
Journal Articles

Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients

Attaya Suvannasankha, Sherif Farag, MD, PhD, FRACP, FRCPA, Robin Obryant, RN, Lisa l Wood, RN, Nicole Porter, Rafat Abonour, MD
Journal: Blood
Blood (2010) 116 (21): 1970.
https://doi.org/10.1182/blood.V116.21.1970.1970
Published: 2010
Journal Articles

Phase I Trial of High-Dose Clofarabine and Busulfan as a Myeloablative Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia.

Sherif Farag, MD, PhD, Lisa L Wood, RN, Jennifer E. Schwartz, MD, FRCP(C), Shivani Srivastava, MD, Robert P. Nelson, Jr., MD, Michael Robertson, MD, Rafat Abonour, MD, Hamid Sayar, MD, Larry D. Cripe, MD
Journal: Blood
Blood (2009) 114 (22): 198.
https://doi.org/10.1182/blood.V114.22.198.198
Published: 2009
Journal Articles

Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients.

Attaya Suvannasankha, MD, Sherif Farag, MBBS, PhD, Robin A O'Bryant, RN, Lisa L Wood, RN, Rafat Abonour
Journal: Blood
Blood (2009) 114 (22): 2882.
https://doi.org/10.1182/blood.V114.22.2882.2882
Published: 2009
Journal Articles

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide: A Novel Preparative Regimen Prior to Autologous Peripheral Blood Stem Cell (PBSC) Transplantation in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma.

Sherif Farag, MD, PhD, Lisa L Wood, RN, Shivani Srivastava, MD, Robert P. Nelson, Jr., MD, Jennifer E. Schwartz, MD, FRCP(C), Elizabeth Cox, Rafat Abonour, MD, Michael Robertson, MD,
Journal: Blood
Blood (2009) 114 (22): 3402.
https://doi.org/10.1182/blood.V114.22.3402.3402
Published: 2009